Please login to the form below

Not currently logged in
Email:
Password:

Idea Pharma taps Astellas and Xention for new recruits

The phase II strategy consultancy appoints four new members of staff, including Astellas’ Amy Wasserman and Xention’s Calum Graham

Phase II strategy consultancy Idea Pharma has appointed four new members of staff, including Astellas' Amy Wasserman and Xention's Calum Graham.

Wasserman joins Idea Pharma as director of client value (US) after more than four years at Astellas Pharma US and before that stints at Janssen-Ortho and Solvay.

Meanwhile, Graham has over 20 years' pharma experience, including two years with Xention as director of business development. Prior to that he spent six years at GlaxoSmithKline leading global studies across a wide range of therapeutic areas.

Idea Pharma has also appointed Tristan Allen as European account manager and Claire Hales as office administrator (UK).

Allen was most recently an independent marketing and business development consultant while Hales joins Idea Pharma from the steel coating industry.

14th November 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics